News Sanofi palms off MyoKardia heart disease pact Sanofi has walked away from a four-year-old alliance with US biotech MyoKardia, handing back rights to three drugs for heart disease.
News Verily developing AI-based heart disease test Deep learning AI analyses retinal images to determine heart disease risk.
News AliveCor and Omron create first combined ECG/blood pressure ... Combined app will give patients a more complete view of their heart health.
Patients LSX2026: On promise and patience, with Hans Schambye At LSX World Congress 2026 in Lisbon, Portugal, web editor Nicole Raleigh spoke with Hans Schambye, CEO of BOOST Pharma.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
